Oncolytics Biotech, Inc. (ONCY)
1.13
+0.06
(+5.61%)
USD |
NASDAQ |
Feb 27, 16:00
1.12
-0.01
(-0.88%)
After-Hours: 20:00
Oncolytics Biotech Free Cash Flow : -18.79M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aurinia Pharmaceuticals, Inc. | 135.69M |
| Edesa Biotech, Inc. | -8.004M |
| Lexaria Bioscience Corp. | -8.775M |
| Xenon Pharmaceuticals, Inc. | -280.51M |
| ProMIS Neurosciences, Inc. | -27.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.878M |
| Cash from Investing (Quarterly) | -0.0051M |
| Cash from Financing (Quarterly) | 3.050M |
| Free Cash Flow Per Share (Quarterly) | -0.0482 |
| Free Cash Flow to Equity (Quarterly) | -4.832M |
| Free Cash Flow to Firm (Quarterly) | -4.883M |
| Free Cash Flow Yield | -18.75% |